
In a surprising legal move, Texas Attorney General Ken Paxton has initiated a lawsuit against Kenvue and Johnson & Johnson, the companies behind the widely used pain reliever Tylenol. This action comes amid controversial claims that Tylenol may increase the risk of autism spectrum disorder, a notion heavily promoted by former President Trump and his former health secretary Robert F. Kennedy Jr. Both figures lack formal scientific or medical credentials, yet they have publicly attributed the blame for autism to this common medication. Paxton's lawsuit alleges that Tylenol has been deceptively marketed, suggesting a direct link to autism and other disorders. This assertion is reportedly supported by what he describes as a "considerable body of evidence" highlighted by the Trump Administration. However, the scientific community largely disputes these claims, emphasizing that there is no substantial evidence linking Tylenol to autism. Instead, existing research presents a mixed picture, with many studies indicating no correlation. During a press conference, Trump expressed his concerns about Tylenol, urging pregnant women to avoid it. He stated multiple times, "Don't take Tylenol. There’s no downside. Don’t take it if you’re pregnant. Don’t give it to the baby after the baby is born." While some studies have suggested a potential association between acetaminophen use and autism risk, many of these studies are criticized for their methodological flaws. Notably, a respected study from Sweden found no significant differences in autism risk among siblings exposed to varying levels of acetaminophen during pregnancy, pointing to other factors at play. This lawsuit raises critical questions about the intersection of public health policy and legal action, as the discourse surrounding autism causation continues to evolve amidst ongoing scientific research.
The Pentagon's chief of research and development has revealed the Department of Defense's deep concerns regarding Anthro...
Business Insider | Mar 06, 2026, 21:30In an era where command lines are regaining popularity, Google has unveiled an exciting new tool aimed at enhancing work...
Ars Technica | Mar 06, 2026, 20:00
A recent survey highlights a notable gender disparity in attitudes toward artificial intelligence, revealing that men ar...
CNBC | Mar 06, 2026, 18:55
On September 26, 2022, NASA's Double Asteroid Redirection Test (DART) spacecraft made history by colliding with a binary...
Ars Technica | Mar 06, 2026, 19:05
X is piloting a novel advertising format that integrates product recommendations directly beneath relevant posts. This i...
TechCrunch | Mar 06, 2026, 23:00